Patent · US Active

Insulin-mimetics as therapeutic adjuncts for bone regeneration

US9265794B2 · kind B2 · utility

4Cited by

7References

6Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Sheldon S. Lin · Chatham, US
David N. Paglia · Meridian Avenue, US
James P. O'Connor · Menlo Park, US
Joseph Benevenia · Montclair, US
Aaron Wey · East Brunswick Township, US
Sangeeta Subramanian · Jacksonville, US
John Koerner · Newark, US
Paul Chirichella · Fair Lawn, US
Michael J. Vives · Newark, US

Key dates

Filing date	Aug 26, 2014
Grant date	Feb 23, 2016
Priority date	—
Expiry date	Aug 26, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of promoting bone healing or regeneration by locally administering insulin mimetic agents to patients in need thereof and new uses of insulin-mimetic compounds for accelerating bone-healing processes are disclosed. Bone injury treatment and void filler devices, products and kit suitable for local administration of insulin-mimetic agents or compositions thereof to patients in need of such treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.